Seres Therapeutics, Laboratory and Clinical Manufacturing Facility

This project was a fit-out of approximately 85,000 sf of cGMP pilot plant, laboratory, and office space at 200 Sidney Street in Cambridge, Massachusetts.

Location: Massachusetts
Sector: Microbiome Therapy

About This Project

Seres Therapeutics is creating a new class of medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis.

Project Scope

DPS was given an initial contract to complete the Basis of Design (BOD) for Seres new laboratory and clinical manufacturing facilities.  

DPS assumed control of the architecture, engineering, and oversight for Phase 2 of the project comprising an animal care facility (ACF), laboratories, office space, and a GMP pilot plant. The work included issue for permit, issue for construction, and construction administration activities.

Back to top
DPS Group addresses the COVID-19 pandemic:
A message from Frank Keogh, CEO

Find out more Contact Us